Peripheral decarboxylase inhibitor, used in combination with levodopa for treatment of Parkinsonism.
Soluble to 20 mM in DMSO
Store at RT
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
L-Dopa infusion experiments in combination with the L-dopa decarboxylase inhibitors benserazide and carbidopa - L-dopa metabolism and neuroendocrinological effects.
Kopfhammer et al.